Primary Biliary Cholangitis Market 2028 By Treatment Type, Distribution Channel and Geography | The Insight Partners

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Primary Biliary Cholangitis Market - By Treatment Type
1.3.2 Primary Biliary Cholangitis Market - By Distribution Channel
1.3.3 Primary Biliary Cholangitis Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PRIMARY BILIARY CHOLANGITIS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PRIMARY BILIARY CHOLANGITIS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. PRIMARY BILIARY CHOLANGITIS MARKET - GLOBAL MARKET ANALYSIS
6.1. PRIMARY BILIARY CHOLANGITIS - GLOBAL MARKET OVERVIEW
6.2. PRIMARY BILIARY CHOLANGITIS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PRIMARY BILIARY CHOLANGITIS MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT TYPE
7.1. OVERVIEW
7.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
7.3. DRUGS
7.3.1. Overview
7.3.2. Drugs Market Forecast and Analysis
7.3.3. Symptomatic Relief Treatment Market
7.3.3.1. Overview
7.3.3.2. Symptomatic Relief Treatment Market Forecast and Analysis
7.3.4. Ursodeoxycholic Acid (UDCA) Market
7.3.4.1. Overview
7.3.4.2. Ursodeoxycholic Acid (UDCA) Market Forecast and Analysis
7.3.5. Obeticholic Acid (Ocaliva) Market
7.3.5.1. Overview
7.3.5.2. Obeticholic Acid (Ocaliva) Market Forecast and Analysis
7.4. LIVER TRANSPLANTATION
7.4.1. Overview
7.4.2. Liver Transplantation Market Forecast and Analysis
8. PRIMARY BILIARY CHOLANGITIS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. ONLINE PHARMACIES
8.5.1. Overview
8.5.2. Online Pharmacies Market Forecast and Analysis
9. PRIMARY BILIARY CHOLANGITIS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Primary Biliary Cholangitis Market Overview
9.1.2 North America Primary Biliary Cholangitis Market Forecasts and Analysis
9.1.3 North America Primary Biliary Cholangitis Market Forecasts and Analysis - By Treatment Type
9.1.4 North America Primary Biliary Cholangitis Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Primary Biliary Cholangitis Market Forecasts and Analysis - By Countries
9.1.5.1 United States Primary Biliary Cholangitis Market
9.1.5.1.1 United States Primary Biliary Cholangitis Market by Treatment Type
9.1.5.1.2 United States Primary Biliary Cholangitis Market by Distribution Channel
9.1.5.2 Canada Primary Biliary Cholangitis Market
9.1.5.2.1 Canada Primary Biliary Cholangitis Market by Treatment Type
9.1.5.2.2 Canada Primary Biliary Cholangitis Market by Distribution Channel
9.1.5.3 Mexico Primary Biliary Cholangitis Market
9.1.5.3.1 Mexico Primary Biliary Cholangitis Market by Treatment Type
9.1.5.3.2 Mexico Primary Biliary Cholangitis Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Primary Biliary Cholangitis Market Overview
9.2.2 Europe Primary Biliary Cholangitis Market Forecasts and Analysis
9.2.3 Europe Primary Biliary Cholangitis Market Forecasts and Analysis - By Treatment Type
9.2.4 Europe Primary Biliary Cholangitis Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Primary Biliary Cholangitis Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Primary Biliary Cholangitis Market
9.2.5.1.1 Germany Primary Biliary Cholangitis Market by Treatment Type
9.2.5.1.2 Germany Primary Biliary Cholangitis Market by Distribution Channel
9.2.5.2 France Primary Biliary Cholangitis Market
9.2.5.2.1 France Primary Biliary Cholangitis Market by Treatment Type
9.2.5.2.2 France Primary Biliary Cholangitis Market by Distribution Channel
9.2.5.3 Italy Primary Biliary Cholangitis Market
9.2.5.3.1 Italy Primary Biliary Cholangitis Market by Treatment Type
9.2.5.3.2 Italy Primary Biliary Cholangitis Market by Distribution Channel
9.2.5.4 Spain Primary Biliary Cholangitis Market
9.2.5.4.1 Spain Primary Biliary Cholangitis Market by Treatment Type
9.2.5.4.2 Spain Primary Biliary Cholangitis Market by Distribution Channel
9.2.5.5 United Kingdom Primary Biliary Cholangitis Market
9.2.5.5.1 United Kingdom Primary Biliary Cholangitis Market by Treatment Type
9.2.5.5.2 United Kingdom Primary Biliary Cholangitis Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Primary Biliary Cholangitis Market Overview
9.3.2 Asia-Pacific Primary Biliary Cholangitis Market Forecasts and Analysis
9.3.3 Asia-Pacific Primary Biliary Cholangitis Market Forecasts and Analysis - By Treatment Type
9.3.4 Asia-Pacific Primary Biliary Cholangitis Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Primary Biliary Cholangitis Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Primary Biliary Cholangitis Market
9.3.5.1.1 Australia Primary Biliary Cholangitis Market by Treatment Type
9.3.5.1.2 Australia Primary Biliary Cholangitis Market by Distribution Channel
9.3.5.2 China Primary Biliary Cholangitis Market
9.3.5.2.1 China Primary Biliary Cholangitis Market by Treatment Type
9.3.5.2.2 China Primary Biliary Cholangitis Market by Distribution Channel
9.3.5.3 India Primary Biliary Cholangitis Market
9.3.5.3.1 India Primary Biliary Cholangitis Market by Treatment Type
9.3.5.3.2 India Primary Biliary Cholangitis Market by Distribution Channel
9.3.5.4 Japan Primary Biliary Cholangitis Market
9.3.5.4.1 Japan Primary Biliary Cholangitis Market by Treatment Type
9.3.5.4.2 Japan Primary Biliary Cholangitis Market by Distribution Channel
9.3.5.5 South Korea Primary Biliary Cholangitis Market
9.3.5.5.1 South Korea Primary Biliary Cholangitis Market by Treatment Type
9.3.5.5.2 South Korea Primary Biliary Cholangitis Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Primary Biliary Cholangitis Market Overview
9.4.2 Middle East and Africa Primary Biliary Cholangitis Market Forecasts and Analysis
9.4.3 Middle East and Africa Primary Biliary Cholangitis Market Forecasts and Analysis - By Treatment Type
9.4.4 Middle East and Africa Primary Biliary Cholangitis Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Primary Biliary Cholangitis Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Primary Biliary Cholangitis Market
9.4.5.1.1 South Africa Primary Biliary Cholangitis Market by Treatment Type
9.4.5.1.2 South Africa Primary Biliary Cholangitis Market by Distribution Channel
9.4.5.2 Saudi Arabia Primary Biliary Cholangitis Market
9.4.5.2.1 Saudi Arabia Primary Biliary Cholangitis Market by Treatment Type
9.4.5.2.2 Saudi Arabia Primary Biliary Cholangitis Market by Distribution Channel
9.4.5.3 U.A.E Primary Biliary Cholangitis Market
9.4.5.3.1 U.A.E Primary Biliary Cholangitis Market by Treatment Type
9.4.5.3.2 U.A.E Primary Biliary Cholangitis Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Primary Biliary Cholangitis Market Overview
9.5.2 South and Central America Primary Biliary Cholangitis Market Forecasts and Analysis
9.5.3 South and Central America Primary Biliary Cholangitis Market Forecasts and Analysis - By Treatment Type
9.5.4 South and Central America Primary Biliary Cholangitis Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Primary Biliary Cholangitis Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Primary Biliary Cholangitis Market
9.5.5.1.1 Brazil Primary Biliary Cholangitis Market by Treatment Type
9.5.5.1.2 Brazil Primary Biliary Cholangitis Market by Distribution Channel
9.5.5.2 Argentina Primary Biliary Cholangitis Market
9.5.5.2.1 Argentina Primary Biliary Cholangitis Market by Treatment Type
9.5.5.2.2 Argentina Primary Biliary Cholangitis Market by Distribution Channel
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. PRIMARY BILIARY CHOLANGITIS MARKET, KEY COMPANY PROFILES
11.1. ZYDUS PHARMACEUTICALS, INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. TAGI PHARMA, INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. INTERCEPT PHARMACEUTICALS, INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ALLERGAN
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. AMNEAL PHARMACEUTICALS LLC
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. MYLAN N.V
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. LANNETT
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. HIKMA PHARMACEUTICALS PLC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. GEMINI PHARMACEUTICALS.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. BRISTOL-MYERS SQUIBB COMPANY
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS